Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1974-11-15
1976-06-22
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
2605024P, 2605024R, 2605025, A61K 4300, C07F 902
Patent
active
039652548
ABSTRACT:
Composition in unit dosage form comprising mono-, di- and polyphosphonate compounds having therapeutic levels of radioactive phosphorus (as .sup.32 P and .sup.33 P) incorporated therein are disclosed. Due to the extremely high affinity of the polyphosphonate compounds for active bone tumors and their exceptionally low retention in soft tissue they are ideal for therapy of both primary and metastatic bone tumors and soft tissue tumors which calcify.
REFERENCES:
patent: 3213129 (1965-10-01), Berth et al.
patent: 3336221 (1967-08-01), Ralston
patent: 3387024 (1968-06-01), Quimby
patent: 3400151 (1968-09-01), Quimby et al.
patent: 3532639 (1970-10-01), Hatch
patent: 3553314 (1971-01-01), Francis
patent: 3553315 (1971-01-01), Francis
patent: 3579570 (1971-05-01), Nicholson et al.
patent: 3743688 (1973-07-01), Nicholson et al.
Francis Marion David
Tofe Andrew John
Nucker Christine M.
Padgett Benjamin R.
The Procter & Gamble & Company
LandOfFree
Compositions for the treatment of calcific tumors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions for the treatment of calcific tumors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for the treatment of calcific tumors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2288789